TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank20
3Y CAGR-59.0%
5Y CAGR-64.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-59.0%/yr
vs -15.5%/yr prior
5Y CAGR
-64.0%/yr
Recent acceleration
Acceleration
-43.6pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $96000.00 | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $1.40M | -0.4% |
| 2021 | $1.40M | -91.2% |
| 2020 | $15.97M | +152.2% |
| 2019 | $6.33M | +131.4% |
| 2018 | $2.74M | +3.8% |
| 2017 | $2.64M | -37.0% |
| 2016 | $4.19M | - |